University of Wisconsin-Madison Researchers Uncover New Treatment Option for Drug-Resistant Brain Tumor

New research from the University of Wisconsin-Madison explains why glioblastoma multiforme (GBM), the incurable brain cancer, is highly resistant to current chemotherapies.

The study – which hails from the brain-tumor research lab of John Kuo, MD, assistant professor of neurological surgery and human oncology at UW School of Medicine and Public Health – also reports success for a combination therapy that knocks out signaling of multiple members of the epidermal growth factor receptor (EGFR) family in brain-cancer cells. For more information, click here to read the full release.